Chemotherapy-induced nausea and vomiting (CINV) is type of nausea and vomiting caused by cancer drugs dosage. Cancer patient may experience nausea and vomiting within 24 hours (acute type) or after 24 hours (delayed type) of chemotherapy medication. Chemotherapy-induced nausea and vomiting leads to the deferment or refusal of therapeutic chemotherapy treatment for cancer.
MARKET DYNAMICS
Factors driving growth of Chemotherapy-induced Nausea and Vomiting Drugs market during the forecast period are the increasing number of government initiatives in oncology research, rising number of oncology research and development activities, growing incidence of cancer cases, rising adoption of chemotherapy and combination therapy. These are the major factors driving the Chemotherapy-induced Nausea and Vomiting Drugs market.
MARKET SCOPE
The "Global Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Chemotherapy-induced Nausea and Vomiting Drugs Market with detailed market segmentation by therapy type and geography. The global Chemotherapy-induced Nausea and Vomiting Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Chemotherapy-induced Nausea and Vomiting Drugs Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Chemotherapy-induced Nausea and Vomiting Drugs Market is segmented on basis of therapy type. Based on therapy type, the global Chemotherapy-induced Nausea and Vomiting Drugs Market is segmented into dopamine antagonists, serotonin receptor antagonists, benzodiazepines, and neurokinin NK1 receptor antagonist.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Chemotherapy-induced Nausea and Vomiting Drugs Market based on various segments. It also provides market size and forecast estimates from year 2019 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Chemotherapy-induced Nausea and Vomiting Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Chemotherapy-induced Nausea and Vomiting Drugs Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Chemotherapy-induced Nausea and Vomiting Drugs Market in these regions.
MARKET PLAYERS
The reports cover key developments in the Chemotherapy-induced Nausea and Vomiting Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Chemotherapy-induced Nausea and Vomiting Drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for activated carbon maskin the global market. Below mentioned is the list of fewcompanies engaged in the Chemotherapy-induced Nausea and Vomiting Drugs Market.
The report also includes the profiles of key Chemotherapy-induced Nausea and Vomiting Drugs Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GlaxoSmithKline plc
- Merck and Co., Inc
- Teva Pharmaceuticals
- Heron Therapeutics, Inc.
- F. Hoffmann-La Roche AG
- Tesaro, Inc.
- Acacia Pharma
- Baxter international Inc.
- Lee's Pharmaceutical Holdings
- Mundipharma International limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.